首页|Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection

Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据

Jingwei Bian、Rongsheng Zhao、Suodi Zhai、Ziiian Li

展开 >

Department of Pharmacy, Peking University Third Hospital,Beijing 100083, China

Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital

Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Ministry of Health

Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education

Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100083, China

展开 >

authors acknowledge funding support from the National Natural Science Foundation of Chinaauthors acknowledge funding support from the National Natural Science Foundation of Chinaauthors acknowledge funding support from the National Natural Science Foundation of Chinaauthors acknowledge funding support from the National Natural Science Foundation of Chinaauthors acknowledge funding support from the National Natural Science Foundation of ChinaBeijing Municipal Natural Science FoundationBeijing Municipal Natural Science Foundation

919393018182010803191539123814718937172235China

2020

药学学报(英文版)

药学学报(英文版)

CSTPCDCSCDSCI
ISSN：
年,卷(期)：2020.10(7)
  • 3
  • 10